Pharmafile Logo

Clinical Trial Enrollment

- PMLiVE

Lilly’s Omvoh shows improved outcomes in ulcerative colitis

The phase 3 trial results demonstrated improved symptomatic, clinical and quality-of-life measures

- PMLiVE

Ireland’s largest cancer research initiative launches second phase

Precision Oncology Ireland is focused on advancing personalised cancer research and care

- PMLiVE

Epsilogen appoints Cristina Oliva as chief medical officer

Oliva was most recently CMO at BerGenBio

- PMLiVE

Setting the direction – how exemplary brand teams brief their agency partners

The three things that separate ordinary agency briefs from great ones

- PMLiVE

Your Blueprint for Flawless Pharma Omnichannel

Learn how to eliminate silos, transform data into actionable insights, and drive unparalleled efficiency across your key initiatives. Secure your spot in our free webinar, exclusive for life science professionals!

Impetus Digital

Build a KOL Community Virtually – Engaging Your Advisors Creatively

Go beyond formal meetings! Discover a creative way to build a virtual KOL community through ongoing discussion forums. Facilitate peer-to-peer best practice sharing and foster authentic, sustained relationships with your...

Impetus Digital

- PMLiVE

Resonant Group’s CEO celebrated for driving innovation and professional excellence across the healthcare communications sector

Resonant Group’s CEO celebrated for driving innovation and professional excellence across the healthcare communications sector

Bedrock Healthcare Communications

- PMLiVE

MHRA and FDA expand collaboration on AI and medtech regulation

National Commission on the Regulation of AI in Healthcare brings together UK and US experts

- PMLiVE

Lilly appoints former US FDA director Peter Marks to lead infectious disease division

Marks joins the drugmaker after resigning from the FDA in March

- PMLiVE

Uniphar On Track to Achieve SBTi Target of Halving Scope 1 and 2 Emissions by 2030

[Dublin, 9th October 2025] Uniphar, a global leader in pharmaceutical and medtech solutions, is making progress towards its near-term Science Based Targets initiative (SBTi) goal of halving Scope 1 and...

Uniphar

- PMLiVE

Delivering purposeful solutions at Obesity Week 2025

We’re attending Obesity Week 2025, the world’s leading event dedicated to obesity research and care, to showcase how our integrated expertise is advancing progress in obesity and cardiometabolic health.

Inizio

- PMLiVE

Speak up to step forward

Why the employee voice deserves more than lip service

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links